Skip to main content

Table 7 Sensitivity analysis of two scenarios (intention-to-treat and original evaluation study), with the difference-in-difference (DiD) estimator (ATT) and its standard error (SE)

From: Cost-effectiveness analysis of a chronic back pain multidisciplinary biopsychosocial rehabilitation (MBR) compared to standard care for privately insured in Germany

Intention-to-treat (1)

Overall

n= 136 (MBR) and 137 (controls)

Minor impairment

n= 74 (MBR) and 80 (controls)

Major impairment

n = 62 (MBR) and 57 (controls)

Item

ATTa

SE

ATTa

SE

ATTa

SE

Total cost (€)

755

2447

2981

2864

-1762

4249

 Back pain-related cost (€)

-128

677

569

882

-959

1019

 Inpatient cost – back pain (€)

231

535

971

697

-704

824

 Outpatient cost – back pain (€)

-359

381

-402

498

-256

562

Sick leave in last 6 months due to back painb

-13.58*

3.13

-7.24†

2.9

-22.04*

6.24

Overall health status (EQ-5D)b

0.027

0.01

0.024

0.02

0.025

0.02

Original evaluation study (2)

Overall

n= 186 (MBR) and 249 (controls)

Minor impairment

n= 88 (MBR) and 147 (controls)

Major impairment

n= 98 (MBR) and 102 (controls)

Item

ATTa

SE

ATTa

SE

ATTa

SE

Total cost (€)

2845

2365

5330†

2990

1217

3811

 Back pain-related cost (€)

537

869

1022

1046

488

1451

 Inpatient cost – back pain (€)

650

690

1078

825

540

1185

 Outpatient cost – back pain (€)

-113

380

-56

517

-53

566

Sick leave in last 6 months due to back painb

-12.7**

2.53

-4.68

9.42

-22.84**

4.95

Overall health status (EQ-5D)b

0.030*

0.01

0.011

0.01

0.048*

0.02

  1. † < 0.1; * < 0.05; ** < 0.01; *** < 0.0001
  2. aAverage treatment effect for the treated (ATT) represents the discounted mean differences in outcome
  3. bThese results were not calculated with a DiD regression but with an ANCOVA